https://clinicaltrials.gov/ct2/show/NCT03858686?type=Intr&cond=COPD&phase=01234&lupd_s=02%2F15%2F2019&lupd_d=14&sort=nwst The Effect of FP-025, a MMP-12 Inhibitor, on Allergen-induced Airway Responses and Airway Inflammation in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma Condition : Asthma, COPD Interventions : Drug: FP-025 capsules; Drug: Placebo FP-025 capsules Sponsor : Foresee Pharmaceuticals Co., Ltd. Recruiting NCT03858686 Fri, 01 Mar 2019 12:00:00 EST
